Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-30 1:52 pm Sale | 2026-09-30 | 13G | LANTHEUS HLDGS INC LNTH | Vanguard Portfolio Management | 3,189,870 4.880% | -110,423 (-3.35%) | Filing History |
| 2026-09-23 4:19 pm Sale | 2026-09-21 | 13D | PERSPECTIVE THERAPEUTICS INC C CATX | Lantheus Holdings Inc LNTH | 8,739,011 7.700% | -2,701,502 (-23.61%) | Filing History |
| 2026-09-04 4:48 pm Sale | 2024-05-15 | 13D | PERSPECTIVE THERAPEUTICS INC C CATX | Lantheus Holdings Inc LNTH | 11,440,513 10.000% | -236,826 (-2.03%) | Filing History |
| 2026-09-04 4:42 pm Unchanged | 2026-07-28 | 13G | RADIOPHARM THERANOSTICS LTD RADX | Lantheus Holdings Inc LNTH | 792,958,513 17.300% | 0 (Unchanged) | Filing History |
| 2026-09-04 4:40 pm Purchase | 2024-11-27 | 13D | RADIOPHARM THERANOSTICS LTD RADX | Lantheus Holdings Inc LNTH | 792,958,513 20.900% | 792,958,513 (New Position) | Filing History |
| 2026-08-13 5:16 pm Purchase | 2026-06-30 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Management, L.L.C. | 5,583,479 8.600% | 5,583,479 (New Position) | Filing History |
| 2026-07-31 11:19 am Purchase | 2026-06-30 | 13G | LANTHEUS HLDGS INC LNTH | Vanguard Portfolio Management | 3,300,293 5.060% | 3,300,293 (New Position) | Filing History |
| 2026-05-15 12:38 pm Sale | 2026-03-31 | 13G | LANTHEUS HLDGS INC LNTH | JANUS HENDERSON GROUP Ltd. JHG | 4,774,841 7.400% | -932,406 (-16.34%) | Filing History |
| 2026-04-30 11:00 am Purchase | 2026-03-31 | 13G | LANTHEUS HLDGS INC LNTH | Vanguard Capital Management | 3,421,414 5.250% | 3,421,414 (New Position) | Filing History |
| 2026-03-27 10:20 am Sale | 2026-03-13 | 13G | LANTHEUS HLDGS INC LNTH | VANGUARD GROUP INC | 0 0.000% | -6,973,141 (Position Closed) | Filing History |
| 2026-02-17 4:34 pm Sale | 2025-12-31 | 13G | LANTHEUS HLDGS INC LNTH | JANUS HENDERSON GROUP Ltd. JHG | 5,707,247 8.600% | -977,490 (-14.62%) | Filing History |
| 2026-02-12 12:50 pm Sale | 2025-12-31 | 13G | LANTHEUS HLDGS INC LNTH | MORGAN STANLEY MS | 1,640,837 2.500% | -2,136,875 (-56.57%) | Filing History |
| 2026-02-05 2:59 pm Purchase | 2025-12-31 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 5,427,479 8.200% | 1,950,252 (+56.09%) | Filing History |
| 2025-11-14 12:03 pm Sale | 2025-09-30 | 13G | LANTHEUS HLDGS INC LNTH | JANUS HENDERSON GROUP Ltd. JHG | 6,684,737 9.800% | -254,247 (-3.66%) | Filing History |
| 2025-11-12 12:22 pm Sale | 2025-09-30 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 3,477,227 5.100% | -2,546,000 (-42.27%) | Filing History |
| 2025-11-07 12:14 pm Purchase | 2025-09-30 | 13G | LANTHEUS HLDGS INC LNTH | MORGAN STANLEY MS | 3,777,712 5.600% | 3,777,712 (New Position) | Filing History |
| 2025-11-05 11:40 am Sale | 2025-09-30 | 13G | LANTHEUS HLDGS INC LNTH | FMR LLC | 4,399,524 6.500% | -824,212 (-15.78%) | Filing History |
| 2025-08-14 11:17 am Sale | 2025-06-30 | 13G | LANTHEUS HLDGS INC LNTH | JANUS HENDERSON GROUP Ltd. JHG | 6,938,984 10.000% | -16,071 (-0.23%) | Filing History |
| 2025-08-06 12:06 pm Purchase | 2025-06-30 | 13G | LANTHEUS HLDGS INC LNTH | FMR LLC | 5,223,736 7.500% | 5,223,736 (New Position) | Filing History |
| 2025-06-06 11:59 am Purchase | 2025-05-30 | 13G | LANTHEUS HLDGS INC LNTH | JANUS HENDERSON GROUP Ltd. JHG | 6,955,055 10.100% | 439,569 (+6.75%) | Filing History |